Regeneron has different aims from the ones 23andMe presented to consumers, according to Dr Jennifer King, privacy and data policy Fellow at the Stanford Institute for Human-Centered Artificial Intelligence.
Dr. King, who has interviewed multiple 23andMe users for her research, said the company "always led with the non-profit 'we're helping humanity' side which helped obscure its for-profit mission".
But she added a profit-driven mission was likely to be clearer to customers now that it "is in the sole control of a company that is doing genetic research for pharmaceutical development".
- Date Published:5.19.2025
- Original Publication: BBC